Supplementary Table S1 from Inhibition of Tumor Growth and Metastasis in Non–Small Cell Lung Cancer by LY2801653, an Inhibitor of Several Oncokinases, Including MET

MLA

Richard A. Walgren, et al. Supplementary Table S1 from Inhibition of Tumor Growth and Metastasis in Non–Small Cell Lung Cancer by LY2801653, an Inhibitor of Several Oncokinases, Including MET. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22448849.

APA

Richard A. Walgren, S. Betty Yan, John A. Wijsman, Lei Yan, Gregory P. Donoho, Victoria L. Peek, Jason R. Manro, Kelly M. Credille, Chen Bi, & Wenjuan Wu. (2023). Supplementary Table S1 from Inhibition of Tumor Growth and Metastasis in Non–Small Cell Lung Cancer by LY2801653, an Inhibitor of Several Oncokinases, Including MET. https://doi.org/10.1158/1078-0432.22448849

Chicago

Richard A. Walgren, S. Betty Yan, John A. Wijsman, Lei Yan, Gregory P. Donoho, Victoria L. Peek, Jason R. Manro, Kelly M. Credille, Chen Bi, and Wenjuan Wu. 2023. “Supplementary Table S1 from Inhibition of Tumor Growth and Metastasis in Non–Small Cell Lung Cancer by LY2801653, an Inhibitor of Several Oncokinases, Including MET,” March. doi:10.1158/1078-0432.22448849.